Early and late postnatal myocardial and vascular changes in a protein restriction rat model of intrauterine growth restriction

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Menendez Castro, Carlos ^a   Fahlbusch, Fabian ^a   Cordasic, Nada ^a   Amann, Kerstin ^a   Münzel, Kathrin ^a   Plank, Christian ^a   Wachtveitl, Rainer ^a   Rascher, Wolfgang ^a   Hilgers, Karl F ^a   Hartner, Andrea ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENCE; ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE EXPRESSION; GROWTH INHIBITION; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RESTRICTION; LITTER SIZE; MALE; MATERNAL NUTRITION; NEWBORN; NONHUMAN; PATHOGENESIS; PERINATAL PERIOD; PREGNANCY; PROGENY; PROTEIN DIET; PROTEIN EXPRESSION; PROTEIN RESTRICTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; ANIMAL; BLOOD PRESSURE; CYTOLOGY; FEMALE; INTRAUTERINE GROWTH RETARDATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; ANIMALS, NEWBORN; AORTA; BLOOD PRESSURE; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; DIET, PROTEIN-RESTRICTED; FEMALE; FETAL GROWTH RETARDATION; IMMUNOHISTOCHEMISTRY; MYOCARDIUM; OSTEOPONTIN; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR;

EID: 79957796725     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020369     Document Type: Article

References (59)

1. Barker DJ, (1998) In utero programming of chronic disease. Clin Sci (Lond) 95: 115-128.
2. McMillen IC, Robinson JS, (2005) Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 85: 571-633.
3. Crispi F, Bijnens B, Figueras F, Bartrons J, Eixarch E, et al. (2010) Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation 121: 2427-2436.
4. Crispi F, Hernandez-Andrade E, Pelsers MM, Plasencia W, Benavides-Serralde JA, et al. (2008) Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. Am J Obstet Gynecol 199: 254 e251-258.
5. Martyn CN, Gale CR, Jespersen S, Sherriff SB, (1998) Impaired fetal growth and atherosclerosis of carotid and peripheral arteries. Lancet 352: 173-178.
6. Barker DJ, (1995) Fetal origins of coronary heart disease. Bmj 311: 171-174.
7. Barker DJ, (2000) In utero programming of cardiovascular disease. Theriogenology 53: 555-574.
8. Tintu A, Rouwet E, Verlohren S, Brinkmann J, Ahmad S, et al. (2009) Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences. PLoS One 4: e5155.
9. Ream M, Ray AM, Chandra R, Chikaraishi DM, (2008) Early fetal hypoxia leads to growth restriction and myocardial thinning. Am J Physiol Regul Integr Comp Physiol 295: R583-595.
10. Wang Z, Huang Z, Lu G, Lin L, Ferrari M, (2009) Hypoxia during pregnancy in rats leads to early morphological changes of atherosclerosis in adult offspring. Am J Physiol Heart Circ Physiol 296: H1321-1328.
11. Martyn CN, Greenwald SE, (1997) Impaired synthesis of elastin in walls of aorta and large conduit arteries during early development as an initiating event in pathogenesis of systemic hypertension. Lancet 350: 953-955.
12. Brodszki J, Lanne T, Marsal K, Ley D, (2005) Impaired vascular growth in late adolescence after intrauterine growth restriction. Circulation 111: 2623-2628.
13. Goodfellow J, Bellamy MF, Gorman ST, Brownlee M, Ramsey MW, et al. (1998) Endothelial function is impaired in fit young adults of low birth weight. Cardiovasc Res 40: 600-606.
14. Skilton MR, Evans N, Griffiths KA, Harmer JA, Celermajer DS, (2005) Aortic wall thickness in newborns with intrauterine growth restriction. Lancet 365: 1484-1486.
15. Vehaskari VM, Woods LL, (2005) Prenatal programming of hypertension: lessons from experimental models. J Am Soc Nephrol 16: 2545-2556.
16. Langley-Evans SC, (1997) Maternal carbenoxolone treatment lowers birthweight and induces hypertension in the offspring of rats fed a protein-replete diet. Clin Sci (Lond) 93: 423-429.
17. Vehaskari VM, Aviles DH, Manning J, (2001) Prenatal programming of adult hypertension in the rat. Kidney Int 59: 238-245.
18. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R, (2001) Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 49: 460-467.
19. Corstius HB, Zimanyi MA, Maka N, Herath T, Thomas W, et al. (2005) Effect of intrauterine growth restriction on the number of cardiomyocytes in rat hearts. Pediatr Res 57: 796-800.
20. Lim K, Zimanyi MA, Black MJ, (2006) Effect of maternal protein restriction in rats on cardiac fibrosis and capillarization in adulthood. Pediatr Res 60: 83-87.
21. Skilton MR, Gosby AK, Wu BJ, Ho LM, Stocker R, et al. (2006) Maternal undernutrition reduces aortic wall thickness and elastin content in offspring rats without altering endothelial function. Clin Sci (Lond) 111: 281-287.
22. Plank C, Ostreicher I, Hartner A, Marek I, Struwe FG, et al. (2006) Intrauterine growth retardation aggravates the course of acute mesangioproliferative glomerulonephritis in the rat. Kidney Int 70: 1974-1982.
23. Hartner A, Porst M, Gauer S, Prols F, Veelken R, et al. (2001) Glomerular osteopontin expression and macrophage infiltration in glomerulosclerosis of DOCA-salt rats. Am J Kidney Dis 38: 153-164.
24. Ruiz V, Ordonez RM, Berumen J, Ramirez R, Uhal B, et al. (2003) Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol 285: L1026-1036.
25. Konishi A, Tazawa C, Miki Y, Darnel AD, Suzuki T, et al. (2003) The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat. J Steroid Biochem Mol Biol 85: 439-442.
26. Hui AY, Leung WK, Chan HL, Chan FK, Go MY, et al. (2006) Effect of celecoxib on experimental liver fibrosis in rat. Liver Int 26: 125-136.
27. Uno Y, Horii A, Umemoto M, Hasegawa T, Doi K, et al. (2000) Effects of hypergravity on morphology and osteopontin expression in the rat otolith organs. J Vestib Res 10: 283-289.
28. Behr TM, Wang X, Aiyar N, Coatney RW, Li X, et al. (2000) Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure. Circulation 102: 1315-1322.
29. Langley-Evans SC, Welham SJ, Sherman RC, Jackson AA, (1996) Weanling rats exposed to maternal low-protein diets during discrete periods of gestation exhibit differing severity of hypertension. Clin Sci (Lond) 91: 607-615.
30. Zeman FJ, (1967) Effect of the young rat of maternal protein restriction. J Nutr 93: 167-173.
31. Tapanainen PJ, Bang P, Wilson K, Unterman TG, Vreman HJ, et al. (1994) Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr Res 36: 152-158.
32. Wigglesworth JS, (1964) Experimental Growth Retardation in the Foetal Rat. J Pathol Bacteriol 88: 1-13.
33. Vuguin PM, (2007) Animal models for small for gestational age and fetal programming of adult disease. Horm Res 68: 113-123.
34. Nusken KD, Dotsch J, Rauh M, Rascher W, Schneider H, (2008) Uteroplacental insufficiency after bilateral uterine artery ligation in the rat: impact on postnatal glucose and lipid metabolism and evidence for metabolic programming of the offspring by sham operation. Endocrinology 149: 1056-1063.
35. Jansson N, Pettersson J, Haafiz A, Ericsson A, Palmberg I, et al. (2006) Down-regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet. J Physiol 576: 935-946.
36. Doherty CB, Lewis RM, Sharkey A, Burton GJ, (2003) Placental composition and surface area but not vascularization are altered by maternal protein restriction in the rat. Placenta 24: 34-38.
37. Rutland CS, Latunde-Dada AO, Thorpe A, Plant R, Langley-Evans S, et al. (2007) Effect of gestational nutrition on vascular integrity in the murine placenta. Placenta 28: 734-742.
38. Alexander BT, (2003) Placental insufficiency leads to development of hypertension in growth-restricted offspring. Hypertension 41: 457-462.
39. Ergaz Z, Avgil M, Ornoy A, (2005) Intrauterine growth restriction-etiology and consequences: what do we know about the human situation and experimental animal models? Reprod Toxicol 20: 301-322.
40. Swali A, McMullen S, Langley-Evans SC, (2010) Prenatal protein restriction leads to a disparity between aortic and peripheral blood pressure in Wistar male offspring. J Physiol 588: 3809-3818.
41. de las Heras N, Ruiz-Ortega M, Ruperez M, Sanz-Rosa D, Miana M, et al. (2006) Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II. J Renin Angiotensin Aldosterone Syst 7: 192-200.
42. Schober JM, Chen N, Grzeszkiewicz TM, Jovanovic I, Emeson EE, et al. (2002) Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood 99: 4457-4465.
43. Oemar BS, Werner A, Garnier JM, Do DD, Godoy N, et al. (1997) Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 95: 831-839.
44. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR, (1996) Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107: 404-411.
45. Cicha I, Yilmaz A, Klein M, Raithel D, Brigstock DR, et al. (2005) Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler Thromb Vasc Biol 25: 1008-1013.
46. Fan WH, Pech M, Karnovsky MJ, (2000) Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. Eur J Cell Biol 79: 915-923.
47. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, et al. (1999) Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 126: 137-145.
48. Chuva de Sousa Lopes SM, Feijen A, Korving J, Korchynskyi O, Larsson J, et al. (2004) Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction. Dev Dyn 231: 542-550.
49. Lim K, Zimanyi MA, Black MJ, (2010) Effect of maternal protein restriction during pregnancy and lactation on the number of cardiomyocytes in the postproliferative weanling rat heart. Anat Rec (Hoboken) 293: 431-437.
50. Xu Y, Williams SJ, O'Brien D, Davidge ST, (2006) Hypoxia or nutrient restriction during pregnancy in rats leads to progressive cardiac remodeling and impairs postischemic recovery in adult male offspring. Faseb J 20: 1251-1253.
51. Briscoe TA, Rehn AE, Dieni S, Duncan JR, Wlodek ME, et al. (2004) Cardiovascular and renal disease in the adolescent guinea pig after chronic placental insufficiency. Am J Obstet Gynecol 191: 847-855.
52. Fomovsky GM, Thomopoulos S, Holmes JW, (2009) Contribution of extracellular matrix to the mechanical properties of the heart. J Mol Cell Cardiol.
53. Bouzeghrane F, Reinhardt DP, Reudelhuber TL, Thibault G, (2005) Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis. Am J Physiol Heart Circ Physiol 289: H982-991.
54. Brew K, Dinakarpandian D, Nagase H, (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477: 267-283.
55. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, et al. (2000) Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864.
56. Tamura A, Shingai M, Aso N, Hazuku T, Nasu M, (2003) Osteopontin is released from the heart into the coronary circulation in patients with a previous anterior wall myocardial infarction. Circ J 67: 742-744.
57. Renault MA, Robbesyn F, Reant P, Douin V, Daret D, et al. (2010) Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy. Circ Heart Fail 3: 431-439.
58. Rosenberg M, Zugck C, Nelles M, Juenger C, Frank D, et al. (2008) Osteopontin, a new prognostic biomarker in patients with chronic heart failure. Circ Heart Fail 1: 43-49.
59. Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I, et al. (2005) Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy. Eur J Heart Fail 7: 755-762.